Cross-resistance in the 2′,2′-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugs-Reference-Cited by-同舟云学术

Cross-resistance in the 2′,2′-difluorodeoxycytidine (gemcitabine)-resistant human ovarian cancer cell line AG6000 to standard and investigational drugs

Published:2000-10 Issue:15 Volume:36 Page:1974-1983
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Bergman A.M.,Giaccone G.,van Moorsel C.J.A.,Mauritz R.,Noordhuis P.,Pinedo H.M.,Peters G.J.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference67 articles.

1. Evaluation of the antitumor activity of a (2′,2′-difluoro-2′-deoxycytidine);Hertel;Cancer Res.,1990

2. The influence of the schedule and the dose of gemcitabine on the anti-tumour efficacy in experimental human cancer;Boven;Br. J. Cancer,1993

3. Cemcitabine;Van Moorsel;The Oncologist,1997

4. Phase II study of gemcitabine (2′,2′-difluorodeoxycytidine) in previously treated ovarian cancer patients;Lund;J. Natl. Cancer Inst.,1994

5. Synergistic interaction between cisplatin and gemcitabine in vitro;Bergman;Clin. Cancer Res.,1996

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early Detection of Pancreatic Cancer using Machine Learning Algorithm;2024 5th International Conference on Mobile Computing and Sustainable Informatics (ICMCSI);2024-01-18

2. Combination of Tissue Microarray Profiling and Multiplexed IHC Approaches to Investigate Transport Mechanism of Nucleoside Analog Drug Resistance;Cancer Systems and Integrative Biology;2023

3. Knockdown of POLA2 increases gemcitabine resistance in lung cancer cells;BMC Genomics;2016-12

4. Precision Medicine and Pancreatic Cancer;Pancreas;2016-11

5. Potent Sensitisation of Cancer Cells to Anticancer Drugs by a Quadruple Mutant of the Human Deoxycytidine Kinase;PLOS ONE;2015-10-20